Third Quarter 2026
Filed Oct 29, 2026Total Revenue grew 4.7% year-over-year to $790.0 million; Adjusted EBITDAC grew 3.8% year-over-year to $244.4 million; Adjusted Diluted Earnings Per Share grew 8.5% to $0.51 per diluted share.
Revenue, net income and adjusted diluted earnings per share increased year over year, while organic revenue growth slowed to 4.0% from 15.0% and Adjusted EBITDAC margin declined to 30.9% from 31.2%.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Q3 2026 Total revenueGAAP | $790.0M | – | 4.7 % |
| Q3 2026 Net commissions and feesGAAP | $775.1M | – | 4.8 % |
| Q3 2026 Fiduciary investment incomeGAAP | $14.88M | – | – |
| Q3 2026 Compensation and benefitsGAAP | $484.2M | – | 9.9 % |
| Q3 2026 General and administrativeGAAP | $107.0M | – | (9.0) % |
| Q3 2026 AmortizationGAAP | $64.28M | – | – |
| Q3 2026 DepreciationGAAP | $4.33M | – | – |
| Q3 2026 Change in contingent considerationGAAP | −$10.66M | – | – |
| Q3 2026 Total operating expensesGAAP | $649.1M | – | 0.8 % |
| Q3 2026 Operating incomeGAAP | $140.8M | – | 27.1 % |
| Q3 2026 Interest expense, netGAAP | $57.26M | – | – |
| Q3 2026 Income from equity method investmentsGAAP | −$11.84M | – | – |
| Q3 2026 Other non-operating incomeGAAP | −$784K | – | – |
| Q3 2026 Income before income taxesGAAP | $96.19M | – | – |
| Q3 2026 Income tax expense (benefit)GAAP | $8.14M | – | – |
| Q3 2026 Net incomeGAAP | $88.05M | – | 40.6 % |
| Q3 2026 Net income attributable to Ryan Specialty Holdings, Inc.GAAP | $36.68M | – | 18.0 % |
| Q3 2026 Compensation and benefits expense ratioGAAP | 61.3 % | – | – |
| Q3 2026 General and administrative expense ratioGAAP | 13.5 % | – | – |
| Q3 2026 Net income marginGAAP | 11.1 % | – | – |
| Q3 2026 Earnings per shareGAAP | $0.30 | – | – |
| Q3 2026 Diluted earnings per shareGAAP | $0.29 | – | – |
| Q3 2026 Organic revenue growth ratenon-GAAP | 4.0 % | – | – |
| Q3 2026 Adjusted compensation and benefits expensenon-GAAP | $443.4M | – | 6.3 % |
| Q3 2026 Adjusted compensation and benefits expense rationon-GAAP | 56.1 % | – | – |
| Q3 2026 Adjusted general and administrative expensenon-GAAP | $102.1M | – | 0.3 % |
| Q3 2026 Adjusted general and administrative expense rationon-GAAP | 12.9 % | – | – |
| Q3 2026 Adjusted EBITDACnon-GAAP | $244.4M | – | 3.8 % |
| Q3 2026 Adjusted EBITDAC marginnon-GAAP | 30.9 % | – | – |
| Q3 2026 Adjusted net incomenon-GAAP | $137.1M | – | 4.1 % |
| Q3 2026 Adjusted net income marginnon-GAAP | 17.4 % | – | – |
| Q3 2026 Adjusted diluted earnings per sharenon-GAAP | $0.51 | – | 8.5 % |
| Nine Months Ended September 30, 2026 Total revenueGAAP | $2.50B | – | 8.8 % |
| Nine Months Ended September 30, 2026 Net commissions and feesGAAP | $2.46B | – | 9.0 % |
| Nine Months Ended September 30, 2026 Total operating expensesGAAP | $2.09B | – | 9.9 % |
| Nine Months Ended September 30, 2026 Operating incomeGAAP | $415.7M | – | 3.4 % |
| Nine Months Ended September 30, 2026 Net incomeGAAP | $237.0M | – | 29.6 % |
| Nine Months Ended September 30, 2026 Diluted earnings per shareGAAP | $0.74 | – | – |
| Nine Months Ended September 30, 2026 Organic revenue growth ratenon-GAAP | 7.3 % | – | – |
| Nine Months Ended September 30, 2026 Adjusted EBITDACnon-GAAP | $803.4M | – | 7.9 % |
| Nine Months Ended September 30, 2026 Adjusted EBITDAC marginnon-GAAP | 32.1 % | – | – |
| Nine Months Ended September 30, 2026 Adjusted net incomenon-GAAP | $466.6M | – | 10.0 % |
| Nine Months Ended September 30, 2026 Adjusted diluted earnings per sharenon-GAAP | $1.75 | – | 15.1 % |
| Nine Months Ended September 30, 2026 Total cash flows provided by operating activitiesGAAP | $306.9M | – | – |
| Nine Months Ended September 30, 2026 Capital expendituresGAAP | −$52.23M | – | – |
| Twelve Months Ended September 30, 2026 Credit Adjusted EBITDACnon-GAAP | $1.09B | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Q3 2026 Wholesale Brokerage net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth. | $394.3M | – | 4.6 % |
| Q3 2026 Binding Authority net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth. | $93.01M | – | 3.8 % |
| Q3 2026 Underwriting Management net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth. | $287.8M | – | 5.4 % |
| Nine Months Ended September 30, 2026 Wholesale Brokerage net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth. | $1.27B | – | 4.6 % |
| Nine Months Ended September 30, 2026 Binding Authority net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth. | $303.2M | – | 6.0 % |
| Nine Months Ended September 30, 2026 Underwriting Management net commissions and feesGrowth in Net commissions and fees in all specialties was primarily driven by solid organic growth. | $886.6M | – | 17.3 % |
Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.
Full Year 2026 outlook
- NoteOrganic Revenue Growth Rate in the mid-single digits for 2026
- NoteAdjusted EBITDAC Margin that is down modestly for 2026, as compared to the prior year
Capital returns
- Returned approximately $173.7 million to shareholders in the third quarter.
- $150.0 million of Class A common stock repurchases, representing 3.5 million shares.
- $23.7 million in dividends and distributions.
- $150.0 million of remaining authorization under its share repurchase program as of September 30, 2026.
- Quarterly dividend of $0.13 per share declared on October 29, 2026, payable on November 24, 2026 to stockholders of record as of the close of business on November 10, 2026.
- $0.06 per share of the quarterly dividend will be funded by free cash flow from Ryan Specialty, LLC.
What drove it
- New client wins, strong renewal retention, and expanded relationships with existing clients.
- Continued flow into the specialty and E&S markets.
- Modest amounts of revenue from acquisitions completed within the trailing twelve months ended September 30, 2026.
- Growth across the majority of casualty lines.
- General and administrative expense declined due to lower Acquisition-related expenses, partially offset by higher Restructuring and related expense due to the Empower Program.
Concerns
- Organic Revenue Growth Rate was 4.0% in the quarter, compared to 15.0% in the prior-year period.
- The Company experienced a moderate decline in its property portfolio.
- Adjusted EBITDAC margin was 30.9%, compared to 31.2% in the prior-year period.
- Compensation and benefits expense increased 9.9% to $484,208 (in thousands), exceeding total revenue growth of 4.7%.
- Restructuring and related expense was $23,852 (in thousands) in the Adjusted EBITDAC reconciliation for the quarter due to the Empower Program.
- Outstanding debt principal was $3.7 billion as of September 30, 2026.
What to watch
- Organic Revenue Growth Rate relative to the full-year guidance of mid-single digits.
- Adjusted EBITDAC Margin relative to guidance for a modest decline for 2026 compared to the prior year.
- The property portfolio following the moderate decline reported in the third quarter.
- Compensation and benefits expense and the compensation and benefits expense ratio.
- The cost, timing and effects of the Empower Program.
- Share repurchases under the $150.0 million remaining authorization.
Balance sheet and cash flow
- Cash and cash equivalents of $168.8 million as of September 30, 2026.
- Outstanding debt principal of $3.7 billion as of September 30, 2026.
- Cash and cash equivalents were $168,811 (in thousands) at September 30, 2026, compared to $158,322 (in thousands) at December 31, 2025.
- Long-term debt was $3,634,056 (in thousands) at September 30, 2026, compared to $3,291,462 (in thousands) at December 31, 2025.
- Total cash flows provided by operating activities were $306,933 (in thousands) for the nine months ended September 30, 2026, compared to $380,421 (in thousands) in the prior-year period.
- Capital expenditures were $(52,233) (in thousands) for the nine months ended September 30, 2026, compared to $(50,678) (in thousands) in the prior-year period.
- Repurchases of Class A common stock were $(450,253) (in thousands) for the nine months ended September 30, 2026.
Analysis
Ryan Specialty reported third-quarter total revenue of $789,963 (in thousands), up 4.7% from $754,577 (in thousands). Net commissions and fees increased 4.8% to $775,081 (in thousands), while fiduciary investment income was $14,882 (in thousands), compared with $15,025 (in thousands). Organic Revenue Growth Rate was 4.0%, down from 15.0% in the prior-year period. Management attributed growth to new client wins, renewal retention, expanded client relationships, specialty and E&S market flow, and modest acquisition revenue. Growth occurred across the majority of casualty lines, while the property portfolio declined moderately.
All three reported specialties expanded in the quarter. Wholesale Brokerage net commissions and fees grew 4.6% to $394,283 (in thousands), Binding Authority increased 3.8% to $93,012 (in thousands), and Underwriting Management rose 5.4% to $287,786 (in thousands). Net commissions and policy fees increased 7.8% to $725,761 (in thousands), and supplemental and contingent commissions increased 13.4% to $33,781 (in thousands). These gains were partly offset by a 57.8% decline in loss mitigation and other fees to $15,539 (in thousands).
Profitability showed a sharp improvement in GAAP net income but a modest decline in the adjusted margin. Total operating expenses increased 0.8% to $649,135 (in thousands), with general and administrative expense down 9.0% but compensation and benefits up 9.9%. Operating income increased 27.1% to $140,828 (in thousands) and net income increased 40.6% to $88,048 (in thousands). Adjusted EBITDAC increased 3.8% to $244,446 (in thousands), but Adjusted EBITDAC margin declined to 30.9% from 31.2%. Adjusted net income increased 4.1% to $137,121 (in thousands), while adjusted net income margin was 17.4% versus 17.5%. Adjusted diluted earnings per share rose 8.5% to $0.51.
For the nine months ended September 30, 2026, total revenue increased 8.8% to $2,501,839 (in thousands), Adjusted EBITDAC increased 7.9% to $803,383 (in thousands), and net income increased 29.6% to $237,026 (in thousands). Operating cash flow was $306,933 (in thousands), compared with $380,421 (in thousands) in the prior-year period, while capital expenditures were $(52,233) (in thousands). The Company returned approximately $173.7 million in the third quarter and repurchased $450,253 (in thousands) of Class A common stock over the first nine months. It ended the quarter with cash and cash equivalents of $168.8 million and outstanding debt principal of $3.7 billion.
The Company maintained full-year guidance for Organic Revenue Growth Rate in the mid-single digits and guided to an Adjusted EBITDAC Margin down modestly from the prior year. The principal reported execution items are sustaining organic growth in an increasingly challenging market, managing compensation and restructuring costs under the Empower Program, and preventing further margin erosion. The moderate decline in property and the lower quarterly organic growth rate are also key demand and mix indicators.
Management, verbatim
We are proud of our third quarter performance, in light of an increasingly challenging market and against our toughest year over year comparison.
Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty
We grew total revenue 4.7%, driven by organic growth of 4.0%. We grew Adjusted EBITDAC by 3.8% and Adjusted Diluted EPS by 8.5%.
Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty
Our team delivered in the face of one of the most challenging markets we have ever seen, retaining high levels of existing business, winning significant new business, and building our pipelines.
Timothy W. Turner, Chief Executive Officer of Ryan Specialty
Not in the filing
stated, not guessed- Previous-release outlook was not provided, so comparison of actual results with prior guidance is unavailable.
- Gross margin was not reported.
- Free cash flow was not reported.
- A GAAP total revenue growth outlook was not provided.
- A GAAP net income margin outlook was not provided.
- A tax-rate outlook was not provided.
- Prior-quarter comparisons were not reported for the presented key metrics.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.